127 related articles for article (PubMed ID: 17294190)
1. Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.
Low JC; Wasan KM; Fazli L; Eberding A; Adomat H; Guns ES
Cancer Chemother Pharmacol; 2007 Nov; 60(6):821-9. PubMed ID: 17294190
[TBL] [Abstract][Full Text] [Related]
2. pH modulation using CsCl enhances therapeutic effects of vitamin D in LNCaP tumor bearing mice.
Guns ES; Xie X; Fedoruk M; Madera C; Cowell S; Mayer LD; Skov K; Gleave ME; Kozlowski P
Prostate; 2005 Aug; 64(3):316-22. PubMed ID: 15754319
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
4. Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo.
O'Reilly T; McSheehy PM; Wenger F; Hattenberger M; Muller M; Vaxelaire J; Altmann KH; Wartmann M
Prostate; 2005 Nov; 65(3):231-40. PubMed ID: 15948135
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
6. Preclinical antitumor activity of the oral platinum analog satraplatin.
Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
[TBL] [Abstract][Full Text] [Related]
7. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
[TBL] [Abstract][Full Text] [Related]
8. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.
Venkateswaran V; Haddad AQ; Fleshner NE; Fan R; Sugar LM; Nam R; Klotz LH; Pollak M
J Natl Cancer Inst; 2007 Dec; 99(23):1793-800. PubMed ID: 18042933
[TBL] [Abstract][Full Text] [Related]
9. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
Evans S; Dizeyi N; Abrahamsson PA; Persson J
Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929
[TBL] [Abstract][Full Text] [Related]
10. Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude mice.
Frydman B; Blokhin AV; Brummel S; Wilding G; Maxuitenko Y; Sarkar A; Bhattacharya S; Church D; Reddy VK; Kink JA; Marton LJ; Valasinas A; Basu HS
J Med Chem; 2003 Oct; 46(21):4586-600. PubMed ID: 14521420
[TBL] [Abstract][Full Text] [Related]
11. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route.
Chou TC; Dong H; Zhang X; Tong WP; Danishefsky SJ
Cancer Res; 2005 Oct; 65(20):9445-54. PubMed ID: 16230408
[TBL] [Abstract][Full Text] [Related]
13. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
[TBL] [Abstract][Full Text] [Related]
14. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
15. A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
Weng JR; Tsai CH; Kulp SK; Wang D; Lin CH; Yang HC; Ma Y; Sargeant A; Chiu CF; Tsai MH; Chen CS
Cancer Res; 2007 Aug; 67(16):7815-24. PubMed ID: 17699787
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Musende AG; Eberding A; Wood C; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Guns ET
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1085-95. PubMed ID: 19301006
[TBL] [Abstract][Full Text] [Related]
17. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
19. A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Musende AG; Eberding A; Wood CA; Adomat H; Fazli L; Hurtado-Coll A; Jia W; Bally MB; Tomlinson Guns ES
Anticancer Drugs; 2012 Jun; 23(5):543-52. PubMed ID: 22481061
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.
Karsenty G; Rocha J; Chevalier S; Scarlata E; Andrieu C; Zouanat FZ; Rocchi P; Giusiano S; Elzayat EA; Corcos J
Prostate; 2009 Aug; 69(11):1143-50. PubMed ID: 19399787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
